Lululemon To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several US-listed companies. Keybanc raised Lululemon's target to $570 and maintained an Overweight rating. Piper Sandler increased Twilio's target to $82 and upgraded to Overweight. Roth MKM raised Live Nation's target to $114 and upgraded to Buy. Barclays increased Couchbase's target to $26 with an Overweight rating. Jefferies raised International Flavors' target to $112 and upgraded to Buy. RBC Capital cut Outset Medical's target to $6 and downgraded to Sector Perform. RBC also lowered Johnson Controls' target to $50 and downgraded to Underperform. Barclays slashed Alibaba's target to $109 but maintained an Overweight rating. Keybanc raised Autodesk's target to $260 with an Overweight rating. Evercore ISI Group increased Ciena's target to $57 and upgraded to Outperform.
January 12, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc raised Autodesk's price target from $245 to $260 and maintained an Overweight rating.
The increased price target and sustained Overweight rating by Keybanc indicate a positive sentiment towards Autodesk, which may lead to a short term increase in its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Barclays increased Couchbase's price target from $23 to $26 and maintained an Overweight rating.
Barclays' raised price target and continued Overweight rating indicate a positive outlook for Couchbase, which could lead to a short term stock price increase.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Evercore ISI Group increased Ciena's price target from $52 to $57 and upgraded the stock from In-Line to Outperform.
The raised price target and upgrade to Outperform by Evercore ISI Group suggest a bullish stance on Ciena, potentially leading to a short term rise in its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Jefferies raised International Flavors' price target from $73 to $112 and upgraded the stock from Hold to Buy.
Jefferies' significant price target increase and upgrade to Buy suggest a strong positive sentiment towards International Flavors, which may lead to a short term stock appreciation.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Keybanc raised Lululemon's price target from $500 to $570 and maintained an Overweight rating.
The increase in price target and the maintenance of an Overweight rating by Keybanc could lead to a positive short term impact on Lululemon's stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Roth MKM boosted Live Nation's price target from $92 to $114 and upgraded the stock from Neutral to Buy.
The increased price target and upgrade to Buy for Live Nation by Roth MKM could positively influence the stock's short term performance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Piper Sandler increased Twilio's price target from $75 to $82 and upgraded the stock from Neutral to Overweight.
The raised price target and upgrade to Overweight by Piper Sandler suggest a bullish outlook, potentially leading to a short term rise in Twilio's stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEUTRAL IMPACT
Barclays slashed Alibaba's price target from $138 to $109 but maintained an Overweight rating.
Despite the reduced price target for Alibaba, Barclays' maintenance of an Overweight rating presents mixed signals, likely resulting in a neutral short term impact on the stock.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
RBC Capital lowered Johnson Controls' price target from $54 to $50 and downgraded the stock from Sector Perform to Underperform.
The reduction in price target and downgrade to Underperform by RBC Capital suggest a bearish view on Johnson Controls, which could lead to a short term decline in its stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
RBC Capital cut Outset Medical's price target from $14 to $6 and downgraded the stock from Outperform to Sector Perform.
The lowered price target and downgrade to Sector Perform by RBC Capital could negatively impact Outset Medical's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90